市場調査レポート
商品コード
1439937
フィルフィニッシュ製造 - 世界市場の考察、競合情勢、市場予測(2030年)Fill Finish Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
フィルフィニッシュ製造 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界のフィルフィニッシュ製造の市場規模は、2023年に95億9,289万米ドル、2030年までに169億4,787万米ドルに達し、2024年~2030年の予測期間にCAGRで9.99%の成長が見込まれます。市場は、さまざまな疾病によりフィルフィニッシュ製造プロセスへの需要が高まっていることや、人的介入が少なくて済むこと、汚染の可能性が最小であることなどの要因により、活況を示す見込みです。市場における技術開発の進行は、この部門で行われている合併買収とともに、予測期間(2024年~2030年)に市場の大きな収益成長をもたらすと見込まれています。
フィルフィニッシュ製造の市場力学
フィルフィニッシュ製造市場の注目すべき促進要因は、腫瘍や神経、COVID-19の発症などのさまざまな疾患の流行に起因する、近年のフィルフィニッシュ製造に対する需要の高まりなどです。世界保健機関(WHO)(2023)によると、毎年平均で40万人の子供ががんを発症しています。この資料はさらに、肺がん、乳がん、大腸がん、前立腺がんなど、2020年に世界で1,000万人ががんで死亡したと述べています。さらに、WHO(2023)によれば、現在約5,500万人が認知症を患っており、この数は2030年までに7,800万人、2050年までに1億3,900万人に増加すると予測されています。これらすべての疾患は、患者の生命維持に有益な治療薬、生物製剤、その他の薬剤の形で医療支援を必要とするため、今後数年間にフィルフィニッシュ製造市場の需要が増加します。
また、フィルフィニッシュ製造市場における合併買収の増加は、予測期間に高品質グレードの医薬品と機器の市場需要に拍車をかけると見込まれます。例えば、2020年1月、製薬産業と生物製剤産業向けの完全統合型カスタム、エンドツーエンドカスタムソリューションを提供するAlcami Corporationは、ノースカロライナ州に位置する最新鋭の無菌フィルフィニッシュ製造センターソリューションであるTriPharm Servicesを買収しました。このような近年の発展は、より広範な人々に提供されるフィルフィニッシュサービスの拡大に役立ち、その結果、所定の予測期間にフィルフィニッシュ製造市場全体を前進させます。
しかし、フィルフィニッシュ製品の高いコストや、訓練された専門家の不足による汚染可能性の増加などにより、低開発国や発展途上国でのフィルフィニッシュ製造の採用やアクセスが少なくなり、フィルフィニッシュ製造の市場の成長抑制要因として作用する可能性があります。
フィルフィニッシュ製造市場は、COVID-19パンデミック期間に大きな成長を示しました。COVID-19の症例が増加したため、医薬品と生物製剤の需要が急激に高まり、生産が急増しました。さらに、ワクチンを開発するための研究開発活動や、世界中での大規模な製造要件が、市場成長をさらに後押ししました。さらに、広範な製造施設や産業の開始、将来のさらなるパンデミックを防ぐ集団予防接種に向けた医薬品や潜在的な生物製剤の生産に対する需要の増加が、2024年~2030年の予測期間にフィルフィニッシュ製造市場全体を押し上げると見込まれます。
フィルフィニッシュ製造市場のセグメント分析
フィルフィニッシュ製造市場の製品セグメントでは、消耗品カテゴリが予測期間(2024年~2030年)に市場全体において収益の大幅な成長を記録する見込みです。
これは、消耗品の使用の増加や、今後の無菌状態を維持するための新しい消耗品のニーズ、製品の発売という形での技術開発の高まりによるものと考えられ、これらがフィルフィニッシュ製造市場の製品セグメントにおける消耗品の需要を促進すると予測されます。
消耗品には、無菌状態を維持するために、一度しか使用できず廃棄する必要のあるシリンジ、バイアルなどの種類の機器が含まれます。凍結乾燥におけるバイアルのような消耗品の使用の増加や、生物製剤における使い捨て包装の使用の増加は、この製品セグメントがフィルフィニッシュ製造市場の需要を促進しているさまざまな要因です。
当レポートでは、世界のフィルフィニッシュ製造市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Fill Finish Manufacturing Market By Product (Consumables [Prefilled Syringes, Vials, Cartridges, And Others], Instruments [By System Type {Integrated And Standalone}, By Machine Type {Automated, Semi-Automated And Manual}], By End-User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, And Others), and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to the growing demand for fill finish manufacturing, along with the rising technological advancement and merger acquisitions during the given forecast period.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030. The Fill Finish Manufacturing Market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes owing to a variety of diseases, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Fill Finish Manufacturing Market Dynamics:
Among the noteworthy drivers of the fill-finish manufacturing market, is the rising demand for fill-finish manufacturing in recent times owing to the prevalence of a variety of diseases such as oncological and neurological, and the onset of COVID-19, among others. According to the World Health Organization (2023), 400,000 children develop cancer every year on average. The source further stated that cancer caused 10 million deaths worldwide in 2020, such as lung, breast, colon & rectum, and prostate cancer. Moreover, as per WHO (2023), around 55 million people are currently living with dementia, and this number is expected to rise to 78 million in 2030 and 139 million in 2050. All the given conditions would require medical assistance in the form of therapies, biologics, and other drugs that may be beneficial in sustaining the life of the patient, thus increasing the market demand for the fill-finish manufacturing market in the upcoming years.
Also, the rising merger acquisitions in the fill-finish manufacturing market are expected to spur the market demand for high-quality grade drugs and instruments during the forecast period. For instance, in January 2020, the Alcami Corporation, a provider of fully-integrated custom, end-to-end custom solutions for pharmaceutical and biologics industries acquired TriPharm Services, a new-state-of the-art sterile fill-finish manufacturing center solutions, located in North Carolina. Such recent developments help in the expansion of fill-finish services to be provided to a broader spectrum of people, thus driving the overall market for the fill-finish manufacturing market positively during the given forecast period.
However, the high costs of fill-finish products and increased chances of contamination with a lack of trained professionals and others would lead to less adoption and accessibility of fill-finish manufacturing by underdeveloped or developing countries, thus acting as restraints for the market growth of fill-finish manufacturing.
The fill-finish manufacturing market saw enormous growth during the period of COVID- 19 pandemic. Owing to the rising cases of COVID- 19, the demand and the immediate surge in the production of drugs and biologics exponentially increased. Moreover, the research and developmental activities to develop vaccines and their manufacturing requirement on a large scale worldwide, further pushed the growth of the fill-finish manufacturing market. In addition, the opening of widescale manufacturing units and industries, and the increasing demand for the production of drugs and potential biologics for mass immunization to prevent any further pandemics in the future, are expected to uplift the overall fill-finish manufacturing market during the forecast period from 2024-2030.
Fill Finish Manufacturing Market Segment Analysis:
Fill Finish Manufacturing Market by product (consumables [prefilled syringes, vials, cartridges, and others], instruments [by system type {integrated and standalone}, by machine type {automated, semi-automated and manual}], by end-user (contract manufacturing organizations, pharmaceutical & biopharmaceutical companies, and others), and geography (North America, Europe, Asia-Pacific, and Rest of the World)
Based on the product segment of the Fill Finish Manufacturing Market, the consumables category is projected to register a significant growth in revenue in the overall Fill Finish Manufacturing Market during the forecast period (2024-2030).
This can be ascribed to the increasing use of consumables, the subsequent need for new consumables to maintain sterile conditions, and the rising technological developments in the form of product launches are expected to drive the demand for consumables in the product segment of the fill-finish manufacturing market.
Consumables include various types of syringes, vials, and other types of equipment that can be only used once and need to be discarded, to maintain sterile conditions. The increasing use of consumables such as vials in lyophilization, and their growing use for disposable packaging in biologics are the various factors owing to which the product segment is driving the demand for the fill-finish manufacturing market.
Thereby, considering the growing demand for this segment, numerous new products are being launched in the market. For example, in October 2022, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGaurd SA Pro Safety System for 0.5mL standard glass syringes at Interphex.
Therefore, considering the advantages and the wide applicability associated with the consumables category in the product segment, this segment is expected to generate considerable revenue thereby pushing the overall growth of the global Fill Finish Manufacturing Market during the forecast period.
Asia-Pacific is expected to register the fastest growth in CAGR in the Global Fill-Finish Manufacturing Market:
Among all the regions, Asia-Pacific is expected to register the fastest growth in CAGR in the global Fill Finish Manufacturing Market. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region. For instance, in August 2022, Lonza added capacity at its biologics manufacturing facility in Guangzhou, China, by installing a new fill-finish line unit. In addition, with the costs of material and labor being comparatively cheaper in countries such as India and China, the manufacturing process of the fill-finish market becomes easy, thus driving the global market for the fill-finish manufacturing market. Along with this, the rapid expansion of the biopharmaceutical industry could be a major factor driving the demand for fill-finish manufacturing in the region.
Countries in the Asia-Pacific region such as India and China, being the largest exporters to western companies, have increased their production of APIs. For instance, in August 2020, Wockhardt Ltd, headquartered in Mumbai, India announced a deal with the U.K. government which would supply millions of doses of numerous COVID-19 vaccines, as well as those being formed by AstraZeneca and Oxford University. As part of the deal, the company had also confined fill-and-finish capacity, being the final production step of putting vaccines into syringes or vials and packaging them.
Therefore, the above-mentioned factors are expected to bolster the growth and register a significant CAGR in the Fill Finish Manufacturing Market in the Asia-Pacific region during the forecast period.
Fill Finish Manufacturing Market Key Players:
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
Recent Developmental Activities in the Fill-Finish Manufacturing Market:
In March 2022, SGD pharma launched its ready-to-use sterile 100 ml molded glass vials, which are used for fill finish parental drug products. These glass vials help in proper drug stability and eliminate the chances of scratch on vials to enhance visual inspection.
In February 2022, Moderna and Thermo Fisher scientific underwent long-term strategic collaboration to bolster the range of aseptic fill-finish manufacturing of Spikevax, Covid-19 vaccines, and different mRNA medicines in the US.
In October 2022, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the unveiling of its DeltaCube(TM) Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex.
Key Takeaways from the Fill-Finish Manufacturing Market Report Study
Target Audience who can be benefited from this Fill-Finish Manufacturing Market Report Study
Frequently Asked Questions for the Fill-Finish Manufacturing Market:
Fill Finish Manufacturing refers to the process of filling vials, syringes, and other storage types of equipment with the vaccine, biological & pharmaceutical drug substances along with proper packaging for mass distribution.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030.
The Fill Finish Manufacturing market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
The Asia-Pacific region is expected to have the fastest-growing CAGR in the overall Fill Finish Manufacturing Market during the forecast period from 2024 to 2030. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region.